THE STOCK WIZARDS FOCUS LISTS INCLUDES: (OTCBB: CBIS) Cannabis Science, Inc., (OTC:OWVI) One World Ventures, Inc., (OTCBB: IMGG) Imaging3, Inc. (OTC:NTMG) NT Mining Corp., (OTCBB: ECOB ) EcoBlu Products, Inc.(OTC: SSCCQ) Smurfit-Stone Container Corp.
Receive Our Weekly Top Newsletter Put out Every Weekend Highlighting Penny Stocks, Small Cap & Micro Cap Stocks before They Breakout. The Hottest weekend Newsletter Around http://bit.ly/wttemail
(OTCBB: CBIS — Cannabis Science, Inc.)
Cannabis Science Acquires Two Revenue Producing Operations, a Medical Marijuana Growing Facility and a Dispensary to Facilitate Operational Growth, Research and Development of Pharmaceutical Cannabis Products in Colorado in Accordance With State Laws
COLORADO SPRINGS, Colo., May 24, 2010 Cannabis Science, Inc. (OTCBB:CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce that it has acquired 100% of a private company with two revenue producing operations, an organic medical marijuana growing facility and a medical marijuana dispensary providing patients with medical marijuana in Colorado in accordance with state laws.
Richard Cowan, Cannabis Science CFO, stated, “Obviously, acquiring two revenue producing operations immediately changes the nature of Cannabis Science, giving us a positive cash flow stream much sooner than otherwise would have been possible. We are now entering a new phase of our business and we expect to expand these revenue streams immediately by the acquisition of a larger facility as previously announced to meet the demand for Cannabis Science products. Our main focus remains the development of pharmaceutical cannabis products for FDA approval. In fact, these acquisitions will improve our ability to develop pharmaceuticals and increase our ability to serve the rapidly growing patient community.”
Currently, both operations are producing revenues in the hundreds of thousands of dollars and generate significant positive cash flow. The transaction was a share swap in which the company is issuing a total of 2,400,000 shares for both the acquisition of these operations and as compensation for a management contract that will add significant skills to our company’s team. The seller of these facilities, Mr. Adam Pasquale, is joining the Cannabis Science management team as Director of Horticulture. Mr. Pasquale’s responsibilities include overseeing these operations and implementing the company’s plans to expand these areas of business across the country, as the laws allow. The Company is looking forward to regularly reporting its progress in its 5 key operations:
1. The Horticulture Division — Pharmaceutical Grade Medical Cannabis Grown Under Stringent Quality Controls. 2. Analytical Labs — State Of The Art Facilities Developing Cannabis Extracts and Pharmaceutical Grade Drugs. 3. Manufacturing — Cutting Edge Facilities For Creating Oral and Topical Medications For Various Ailments. 4. Clinical Trials — Initial FDA Clinical Trials Targeting Veterans Suffering From Chronic Pain and PTSD. 5. Distribution — In State Dispensaries Today, National Pharmacies Tomorrow.
Dr. Robert Melamede, PhD., Cannabis Science President and CEO, said, “We view this transaction as key to our plans to develop standardized FDA quality pharmaceutical cannabis products. In addition, their profitability will facilitate our product development in accordance with State laws. These acquisitions will allow us to begin pre-testing to establish the efficacy of our pharmaceutical products prior to formal FDA human trials. We are in preliminary negotiations to establish similar operations in other States that have approved medical marijuana programs addressing the ever-increasing demands for medical marijuana as people learn the truth about marijuana’s unique medical values. We are creating a new type of patient oriented pharmaceutical company that will foster social change, and this is a major step in that process.”
Mr. Cowan added, “I am also very pleased to report that we are currently converting most of the company’s debt into common equity. Adding revenues, eliminating debt, and clarifying the company’s financial structure should help provide a higher per share price and valuation for the company. As a result of the debt conversions, the acquisition, and corporate expansions there are currently 65,570,574 shares outstanding and management expects to retire most of its debt by the end of June thereby eliminating a major source of risk. These developments should allow some of the larger funds and fund managers to invest substantially more in the company because of the reflection of our greater financial strength.”
Richard Cowan continued, “Last January, the New York Times reported that a spokesperson for the U.S. National Institute on Drug Abuse (NIDA) admitted that the agency ‘does not fund research focused on the potential medical benefits of marijuana.’ The NIDA admission explains why these acquisitions are so important for us. It will not only facilitate our research and development; it will also serve as prototype for this sort of operation that we plan to replicate in other medical marijuana states, as well as in other countries. We think that having dispensaries with their own production facilities will allow us to produce ‘Cannabis Science’ branded products that will give patients the best medicine at the best prices. These transactions are further evidence of Dr. Melamede’s ability to bridge the worlds of medical marijuana and hard science, and the patients — and our shareholders — will benefit greatly from this important step. As previously announced, our other steps toward building the company include adding a much larger analytical research laboratories, facilities for developing and manufacturing various delivery modalities such as lozenges, sprays, topical creams etc., as well as wholesale distribution of both nutraceutical and pharmaceutical products.”
The National Organization for the Reform of Marijuana Laws (NORML) explained the significance of this admission:
Under federal law, the agency must approve all clinical and preclinical research involving marijuana. NIDA strictly controls which investigators are allowed access to the federal government’s lone research supply of pot — which is produced and stored at the University of Mississippi.
NIDA spokeswoman Shirley Simson told the Times: “As the National Institute on Drug Abuse, our focus is primarily on the negative consequences of marijuana use. We generally do not fund research focused on the potential beneficial medical effects of marijuana.”
NIDA presently oversees an estimated 85 percent of the world’s research on controlled substances. Commenting on NIDA’s admission NORML Deputy Director Paul Armentano said, “NIDA has finally admitted to the world the ‘Catch-22′ that has been plaguing medical marijuana advocates and patients. Lawmakers demand clinical research regarding the safety and efficacy of medical cannabis, but the agency in charge of such research denies these studies from ever taking place. It’s tragic that these public officials have let political ideology, not science, determine American’s health decisions.”
In 2007, U.S. Drug Enforcement Administration (DEA) Administrative Law Judge Mary Ellen Bittner ruled that NIDA’s monopolization of marijuana research is not “in the public interest,” and ordered the federal government to allow private manufacturers to produce the drug for research purposes. In January of last year, DEA Deputy Administrator Michele Leonhart set aside Judge Bittner’s ruling.
Cannabis Science, Inc.
Cannabis Science is at the forefront of pharmaceutical medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
(OTC: OWVI — One World Ventures, Inc.)
One World Ventures’ Inter Solar Tech Signs Exclusive Distribution Agreement With Caldoris Europe Ltd.
LAS VEGAS, NV, May 24, 2010 One World Ventures, Inc. (PINKSHEETS: OWVI) announced its subsidiary Inter Solar Tech has been selected as the exclusive supplier of solar products to Caldoris Europe Ltd. (Caldoris) and expects revenues of $2 million during the first year of the agreement.
Caldoris is a European renewable energy products expert with an aggressive distribution, marketing, venture capital, and now, a global sourcing plan focusing on serving local wholesalers, retail chains and installation companies as well as large scale business clients. Caldoris conducts business in high growth countries of Eastern Europe (Poland, Czech Republic, Slovakia, Hungary, Romania, Bulgaria) where significant growth in renewables is expected due to E.U. regulatory standards. In Western Europe, Caldoris seeks to leverage the trend towards replacement of local production with Asia based imports and will focus its development in Western Europe on four priority markets: Spain, Italy, France and Germany.
“There’s a great deal of emphasis on green products in the E. U.,” Steve Prior, CEO of One World Ventures explained. “This agreement with Caldoris has been six months in the making and will open up new markets for our products and increase our distribution chain in this growing and vital market.”
About One World Ventures, Inc.: One World Ventures, Inc. is a company with management resourced in Asia, Mexico and the United States that invests in technologies, communities and systems that facilitate trade, finance, communication and travel across international boundaries, cultures and languages. One World Ventures businesses include the financial services 1World Card and 1 World Cash, the alternative energy Inter Solar Tech, (HK), Ltd. and the manufacturing and trading business Tutamen (HK), Ltd.
About Inter Solar Tech: Inter Solar Tech, Ltd. engages in the sale and distribution of renewable power generation products for solar, wind, and hybrid energy projects for both residential and commercial purposes. Inter Solar Tech, Ltd. currently sells its products to a network of distributors and resellers in the People’s Republic of China and the European Union with a plan in place for expansion of its sales and distribution network throughout the rest of the world.
About CALDORIS, Ltd.: www.caldoris.com
Safe Harbor Statement: Any statements contained herein related to future events are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements. One World Ventures, Inc. undertakes no obligation to update any such statements to reflect actual events.
(OTCBB: IMGG — Imaging3, Inc..)
Imaging3 CEO Hosts a Virtual Tour Video of Facility and DViS Demonstration
BURBANK, CA, May 24, 2010 Imaging3(TM), Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced today that a new video has been provided on the company’s Investor Forum website.
The video features a tour of the Imaging3 facility led by Mr. Dean Janes, Chairman and CEO of Imaging3, Inc. In the video, Mr. Janes also demonstrates the DViS’s multi-modality capabilities, which include 2D, 3D real-time and CT slice imagery.
About Imaging3 Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company’s website at http://www.imaging3.com for more information.
(OTC: NTMG — NT Mining Corp.)
NT Mining in Negotiations to Acquire Second Gold Property
LAS VEGAS, NV, May 24, 2010 NT Mining Corporation (PINKSHEETS: NTMG) (the Company) reports that it is negotiating terms with the intention of signing a Letter of Intent (“LOI”) with the owner of a gold property located on Valentine Mountain in southern British Columbia, Canada.
After a recent visit to the mine site, management has concluded that the property has merit and wishes to move forward with the acquisition of its second gold property. The majority of machinery and equipment are already on site, there is good accessibility to the property, and the Southern location experiences mild weather, which will allow for year round production.
This acquisition will allow the Company to reduce costs, increase profitability, and focus on production throughout the year. With two or more projects, the risk factor and operational costs can be shared between the properties thereby increasing profitability.
About NT Mining Corporation: NT Mining Corporation is an exploration and development company conducting operations through its wholly owned Canadian subsidiary “Bullmoose Mines Ltd. The company’s primary asset is the former producing “Bullmoose Gold Mine.” The company plans to re-activate the mine upon completion of the necessary financing and commence operations in the summer of 2010. The mine consists of one mineral lease of 395 acres and 4 mineral claims of 4,771 acres, totaling 5,166 acres. Historical reports show a potential reserve of 1 million ounces of gold (Ross Grunwald P.Eng., 1984) is possible on the mineral lease. Management believes with the expanded area of 4 additional mining claims in 2007, upon completion of expanded drilling programs over the new claims, and on existing known vein structures, a potential of 3 million ounces of gold reserve is possible at the Bullmoose mine. To view a Geological technical report on the property, please click on the following link:
(OTCBB: ECOB — EcoBlu Products, Inc.)
CURRENT NEWS !!
TUFF SHED Continues Use of EcoBlu BLUWOOD Panels
VISTA, Calif., May 21, 2010 EcoBlu Products, Inc. (OTCBB:ECOB) announced today that its National Account TUFF SHED, Inc. has increased its use of EcoBlu’s BLUWOOD(TM) coated panels in the construction of its outdoor storage buildings, garages, and custom buildings. EcoBlu has successfully filled a large order of BLUWOOD(TM) coated panels which was shipped into TUFF SHED’s distribution facility in Texas.
TUFF SHED, Inc. is the largest manufacturer and installer of storage buildings and garages in the United States. The Company currently offers EcoBlu’s BLUWOOD(TM) coated panels as an optional product to protect the structure from mold, rot, decay, and termites.
“We have a great relationship with TUFF SHED and they continue to place orders for BLUWOOD(TM) coated panels. Our technology plays a huge role in the future of wood structures and the consumer continues to drive our markets. TUFF SHED’s recent promotion just shows what is important to the consumer,” said Steve Conboy, President and CEO of EcoBlu Products.
About TUFF SHED, Inc.
TUFF SHED, Inc. is the largest manufacturer and installer of storage buildings and garages in the United States. With 53 factories and more than 1,600 employees nationwide during our peak season, TUFF SHED services residential and commercial customers from coast to coast.
Celebrating its 25th anniversary in 2006, TUFF SHED was founded in 1981 on a simple premise “To provide its customers with a superior product, built by people who care about what they do, and backed by a credible warranty.” The visible difference in engineering design, materials and workmanship has always set TUFF SHED apart from its competitors.
About EcoBlu Products, Inc.
EcoBlu Products, Inc. is a manufacturer of proprietary wood products coated with an eco-friendly chemistry that protects against mold, fungus, rot-decay, wood ingesting insects, termites and fire with EcoBlu’s FRC(TM) technology (Fire Retardant Coating). EcoBlu products utilizing BLUWOOD(TM) and FRC(TM) technology is the ultimate in wood protection, preservation, and fire safety to building components constructed of wood; from joists, beams and paneling, to floors and ceilings.
(OTC: SSCCQ — Smurfit-Stone Container Corp.)
CURRENT NEWS !!
Smurfit-Stone Reaches Agreement With Stockholders
CREVE COEUR, Mo. and CHICAGO, May 24, 2010 Smurfit-Stone Container Corporation today announced that it has reached a resolution with Mariner Investment Group LLC and Senator Investment Group LP, each an investment advisor to funds under management, as holders of the Company’s preferred stock, and funds and accounts managed by P. Schoenfeld Asset Management LP and Fir Tree, Inc., as holders of the Company’s common stock, who were prosecuting objections to the Company’s Chapter 11 Plan of Reorganization (collectively, the “Holders”).
In general, this resolution provides that certain of the new common stock of the reorganized Company that the plan previously provided for distribution to the general unsecured creditors of the Company (the “New SSCC Common Stock Pool”) will now be distributed to the Company’s current stockholders. Specifically, 2.25 percent of the New SSCC Common Stock Pool will be distributed pro rata to the Company’s existing preferred stockholders and 2.25 percent of the New SSCC Common Stock Pool will be distributed pro rata to the Company’s existing common stockholders. Additionally, the resolution provides for the payment of certain of the fees and expenses of the Holders and their professionals. The resolution has the support of the Official Committee of Unsecured Creditors.
“Reaching this agreement with our stockholders is a major milestone for our company and positions us to emerge from bankruptcy in the coming weeks,” said Patrick J. Moore, chairman and CEO of Smurfit-Stone. “Our focus has been, and continues to be, driving value for our stakeholders and helping our customers grow their businesses.”
The Company will ask the United States Bankruptcy Court to approve notice procedures with respect to this resolution and to schedule a hearing to approve the resolution and related non-material modifications to the Company’s Chapter 11 Plan of Reorganization. This resolution resolves all of the objections to the confirmation of the Chapter 11 plan raised by the Holders and as a result, the Company anticipates an exit from Chapter 11 by early Summer 2010.
Smurfit-Stone’s U.S. and Canadian subsidiaries filed voluntary petitions for reorganization under Chapter 11 of the U.S. Bankruptcy Code and under the Companies’ Creditors Arrangement Act (CCAA) in Canada on January 26, 2009.
Smurfit-Stone Container Corporation is one of the industry’s leading integrated containerboard and corrugated packaging producers, and one of the world’s largest paper recyclers. The company is a member of the Sustainable Forestry Initiative(R) and the Chicago Climate Exchange. Smurfit-Stone generated revenue of $5.57 billion in 2009; has led the industry in safety every year since 2001; and conducts its business in compliance with the environmental, health, and safety principles of the American Forest & Paper Association.
Please visit our website for Disclosures and Disclaimers and any conflicts of interest that there may be. http://thestockwizards.net/about/disclaimer/
Forward-Looking Statement: This press release includes “forward-looking statements” within the meaning of the federal securities laws, commonly identified by such terms as “believes,” “looking ahead,” “anticipates,” “estimates” and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company’s projections and expectations are disclosed in the Company’s filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
TheStockWizards.net is not a registered investment advisers or broker/dealer.
TheStockWizards.net makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high risk.
E-mail: info@ Contact: thestockwizards.net